Education
About Us
Working with TipRanks
Follow Us
Brooks Laboratories Limited (IN:BROOKS)
:BROOKS
BROOKS Stock Chart & Stats
₹123.65
-₹3.80(-2.00%)
At close: 4:00 PM EST
₹123.65
-₹3.80(-2.00%)
Day’s Range― - ―
52-Week Range₹93.90 - ₹202.80
Previous CloseN/A
Volume3.81K
Average Volume (3M)2.26K
Market Cap
₹2.85B
Enterprise Value₹4.05B
Total Cash (Recent Filing)₹12.48M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)20.8
Beta1.34
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.71
Shares Outstanding29,457,249
10 Day Avg. Volume1,182
30 Day Avg. Volume2,263
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)3.42
Price to Sales (P/S)4.06
P/FCF Ratio-3.45K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Brooks Laboratories Limited News
BROOKS FAQ
What was Brooks Laboratories Limited’s price range in the past 12 months?
Brooks Laboratories Limited lowest stock price was ₹93.90 and its highest was ₹202.80 in the past 12 months.
What is Brooks Laboratories Limited’s market cap?
Brooks Laboratories Limited’s market cap is ₹2.85B.
When is Brooks Laboratories Limited’s upcoming earnings report date?
Brooks Laboratories Limited’s upcoming earnings report date is Feb 18, 2026 which is in 61 days.
How were Brooks Laboratories Limited’s earnings last quarter?
Brooks Laboratories Limited released its earnings results on Nov 14, 2025. The company reported ₹2.708 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.708.
Is Brooks Laboratories Limited overvalued?
According to Wall Street analysts Brooks Laboratories Limited’s price is currently Overvalued.
Does Brooks Laboratories Limited pay dividends?
Brooks Laboratories Limited does not currently pay dividends.
What is Brooks Laboratories Limited’s EPS estimate?
Brooks Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Brooks Laboratories Limited have?
Brooks Laboratories Limited has 29,457,249 shares outstanding.
What happened to Brooks Laboratories Limited’s price movement after its last earnings report?
Brooks Laboratories Limited reported an EPS of ₹2.708 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.061%.
Which hedge fund is a major shareholder of Brooks Laboratories Limited?
Currently, no hedge funds are holding shares in IN:BROOKS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Brooks Laboratories Limited
Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye and ear drop. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Technical Analysis
Albert David Ltd
―
Medicamen Biotech Limited
―
Medico Remedies Ltd.
―
Nectar Lifesciences Ltd.
―
Zim Laboratories Ltd.
―